Immunotherapy in Allergic Asthma – 5 year analysis: Is it a curative approach?
Saved in:
| Main Authors: | J. Coutinho Costa, J.N. Machado, C. Ferreira, J.M.R. Gama, T. Almeida, A.M. Arrobas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis
2019-05-01
|
| Series: | Pulmonology |
| Online Access: | https://www.tandfonline.com/doi/10.1016/j.pulmoe.2019.01.007 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
by: A. Arrobas, et al.
Published: (2021-03-01) -
Is immunotherapy protective against steroid intake in patients with polysensitized allergic rhinitis and/or asthma?
by: Feridun Gürlek
Published: (2024-11-01) -
Cell surface antigen expression by peripheral blood monocytes in allergic asthma: results of 2.5 years therapy with inhaled beclomethasone dipropionate
by: W. A. T. Slieker, et al.
Published: (1996-01-01) -
Complements and Allergic Asthma
by: Ching-Yuang Lin, et al.
Published: (2019-01-01) -
Impact of immunotherapy with autologous activated T-lymphocytes on clinical parameters and quality of life in patients with allergic bronchial asthma
by: A. E. Makarova, et al.
Published: (2022-04-01)